Ms. Carolyn Bonner reports

MEDICUS PHARMA LTD. ANNOUNCES FILING OF REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING IN THE UNITED STATES

Medicus Pharma Ltd. has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its securities in the United States. The proposed offering is for units consisting of common shares and warrants and the company intends to list its common shares and warrants on a U.S. national securities exchange in conjunction with the offering. The number of securities to be offered and the price range for the proposed offering have not yet been determined. The offering is expected to occur after the SEC completes its review process, subject to market and other conditions.

About Medicus Pharma Ltd.

Medicus Pharma is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets.

We seek Safe Harbor.